Literature DB >> 2359203

An immunohistological study of breast cancer--with special reference to the expression of carbohydrate antigens and estrogen receptor status.

M Sowa1, Y S Chung, Y Kato, M Nishimura, T Kubo, H Maekawa, Y Fujimoto, K Umeyama, M Kawahara.   

Abstract

An investigation carried out on 100 cases of primary breast cancer, both clinicopathologically and immunohistologically, revealed estrogen receptor (ER)-positive cases to be found significantly more often in early stage cancer than advanced stage cancer. On the other hand, ER negative cases were found to have a greater incidence of high-grade lymph node metastasis and were seen significantly more frequently in large tumors. Span-1, CA19-9, and SLEX antigens were detected in 33 per cent, 38 per cent, and 64 per cent of the total cases, respectively and the ratio of ER negative cases was significantly higher in each antigen positive group. Irrespective of the presence or absence of lymph node metastasis, ER negative cases were found significantly more often in antigen-positive groups than in their counterparts and tumor size tended to be greater in the antigen-positive cases. The results of this study thus indicated that the disease progression in breast cancer appears to be correlated with ER status and carbohydrate antigen expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2359203     DOI: 10.1007/bf02470658

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  24 in total

1.  Immunochemical studies of organ and tumor lipids. VI. Isolation and properties of cytolipin H.

Authors:  M M RAPPORT; L GRAF; V P SKIPSKI; N F ALONZO
Journal:  Cancer       Date:  1959 May-Jun       Impact factor: 6.860

2.  General rule for clinical and histological record of mammary cancer. Japan Mammary Cancer Society.

Authors: 
Journal:  Jpn J Surg       Date:  1975-06

3.  [A new series of monoclonal antibodies against pancreatic cancer cells].

Authors:  Y S Chung; K Satake; K Umeyama; Y S Kim
Journal:  Nihon Geka Gakkai Zasshi       Date:  1987-01

4.  Characterization of sialosylated Lewisx as a new tumor-associated antigen.

Authors:  K Fukushima; M Hirota; P I Terasaki; A Wakisaka; H Togashi; D Chia; N Suyama; Y Fukushi; E Nudelman; S Hakomori
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

5.  Specific antigen in serum of patients with colon carcinoma.

Authors:  H Koprowski; M Herlyn; Z Steplewski; H F Sears
Journal:  Science       Date:  1981-04-03       Impact factor: 47.728

6.  Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics.

Authors:  E Thorud; S D Fosså; S Vaage; O Kaalhus; O S Knudsen; O Børmer; M C Shoaib
Journal:  Cancer       Date:  1986-02-15       Impact factor: 6.860

7.  Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.

Authors:  J S Meyer; B Hixon
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

8.  [Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy].

Authors:  T Tominaga
Journal:  Gan No Rinsho       Date:  1983-05

9.  Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.

Authors:  G M Clark; C K Osborne; W L McGuire
Journal:  J Clin Oncol       Date:  1984-10       Impact factor: 44.544

10.  Estrogen receptor: a prognostic factor in breast cancer.

Authors:  N A Samaan; A U Buzdar; K A Aldinger; P N Schultz; K P Yang; M M Romsdahl; R Martin
Journal:  Cancer       Date:  1981-02-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.